
jacc.org/doi/10.1016/j.jacc.… Confirming and quantifying what was suspected - heart failure is evolving. Significant evidence generation implications.

PGY-1 @ Rochester Gen Hospital via @MethodistHosp @Almallah_Labs via @AinshamsMed 🇪🇬 | #cardiology🫀 #R💻 #football⚽️|Tweets My Own.

jacc.org/doi/10.1016/j.jacc.… Confirming and quantifying what was suspected - heart failure is evolving. Significant evidence generation implications.

Original Article: Beta-blockers after Myocardial Infarction with Normal Ejection Fraction nej.md/43U5Ppo @AHAScience | #AHA25

🙏🙏Immensely grateful for the generous support and guidance from Dr. Ann Marie Navar, @virani_md, @ericpetersonMD, and @dramitkhera 🙏🙏 And many thanks to @JAMAInternalMed for offering an avenue to share our findings

How does the move to PREVENT for ASCVD risk estimation affect aspirin use❓ 📜jamanetwork.com/journals/jam… 1⃣ >80% eligible for 1ry prevention aspirin based on a PCE risk >10% would no longer be eligible w/ PREVENT 2⃣ Most current aspirin users don't qualify under either calculator

Biggest move today in clinic: Stopping ASA in pts on DOAC AQUATIC = most important trial of the year. medscape.com/viewarticle/aqu…

Here are my takeaways for the 7 most relevant and important #ESCCongress2025 for generalists AQUATIC, HI-PRO, RETREAT-FRAIL, DIGIT-HF, DAN-RSV were most practicing changing POTCAST was most contentious - not as billed

🙏Incredibly grateful to @almallahmo for supervision , @MalekNayfeh, Fares AlAhdab, Mahmoud Al Rifai, @DmitryAbramovMD, @FudimMarat , @YasMoayedi, @RayanYousefzai for their incredible support, and to @JACCJournals CV imaging for the opportunity to publish our work🙏

Do heart transplant patients always need invasive angio to screen for graft vasculopathy❓ 📜authors.elsevier.com/a/1lWfA… In this meta-analysis, CTA/PET had pretty respectable sensitivity/NPV for ruling out graft vasculopathy compared to a gold standard of invasive angiography.

NEW PAPER in @bmj_latest "Dealing with continuous variables and modelling non-linear associations in healthcare data: practical guide" --> bmj.com/content/390/bmj-2024… #methodologymatters

Over the past 41 years, death due to ischemic heart disease did not decline in countries with low socioeconomic development, research shows @ASayedMD @MethodistHosp @virani_md @ErinMichos @annmarienavar @DrLaPrincess ahajrnls.org/3EWOnYl

🙏🙏Incredibly thankful to @almallahmo and Dr. Al Rifai for their supervision & guidance on this; and to my brilliant colleague @MariaAlwan_ 🙏🙏 And thank you to @EHJCVIEiC for allowing us to share our findings!

Patients with a normal-ish EF could be further stratified as being at a *truly* low-risk of events or at intermediate risk depending on their rest flow. In contrast, patients with a depressed EF had a uniformly high rate of events regardless.

Our hypothesis was that an elevated amount of myocardial blood flow at rest, which PET can measure, would predict adverse event rates. And it did, esp. in patients with a normal EF at rest.

First, some background. Prior data indicated that the myocardium of patients with LVH/HFpEF receives an excessive amount of blood flow at rest (doi.org/10.1161/CIRCHEARTFAI…) There is also mechanistic data that medications effective in HFpEF reduce this (doi.org/10.2337/db20-0921)

1/4🧵 In patients undergoing cardiac stress testing w/ PET, does rest flow matter❓ In an analysis of >8k patients, we find that it does, esp. in patients with a preserved EF. Link📜: doi.org/10.1093/ehjci/jeaf13… @almallahmo @MariaAlwan_ @MyASNC @MethodistHosp @EHJCVIEiC

𝐃𝐒𝐄 𝐝𝐞𝐥𝐢𝐯𝐞𝐫𝐬 𝐢𝐧 𝐎𝐑𝐁𝐈𝐓𝐀-𝟐: Stress echo ischemia identifies who 𝘳𝘦𝘢𝘭𝘭𝘺 benefits from PCI. 📖 𝐉𝐮𝐬𝐭 𝐩𝐮𝐛𝐥𝐢𝐬𝐡𝐞𝐝 𝐢𝐧 #𝐉𝐀𝐂𝐂: bit.ly/42PNCcB @rallamee @mshunshin @rajkumar_chris @MikeFoley89 @FloSimader @ShaynaChotai